Patent ReferencesFormulations providing three distinct releases Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine Delayed, sustained-release propranolol pharmaceutical preparation Immediate release tablet cores of insoluble drugs having sustained-release coating Controlled release formulations coated with aqueous dispersions of acrylic polymers Method of treating pain by administering 24 hour oral opioid formulations Patent #: 5672360 InventorsApplicationNo. 892190 filed on 07/14/1997US Classes:424/459, Organic coatings424/458, Containing discrete coated particles pellets, granules, or beads424/462, Containing solid synthetic polymers424/468, Sustained or differential release type514/317Additional ring containingExaminersPrimary: Henley, III, RaymondAttorney, Agent or FirmInternational ClassesA61K 009/56A61K 009/54 A61K 009/58 A61K 009/22 A61K 031/21 AbstractDosage forms for oral administration of a methylphenidate drug are provided. The dosage forms provide a substantially immediate dose of methylphenidate upon ingestion, followed by one or more additional doses at predetermined times. By providing such a drug release profile, the dosage forms eliminate the need for a patient to carry an additional dose for ingestion during the day. The dosage forms and methods provided are useful in administering methylphenidate and pharmaceutically acceptable salts thereof, which generally require one or more doses throughout the day.Other References
| |